Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Nanologica AB (publ) via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2023-05-03 10:43:00
After successfully implementing fine-tuning in production, Nanologica's product now meets the company's own requirements for quality in all evaluated parameters.
The company is therefore continuing to formally approve products to be able delivery to customers progressively.
”After making further fine-tunings in one of the production steps, we now have a product that we are satisfied with and that we can proudly deliver to customers. Finally! This means that we now can move on with the first deliveries. We still have a lot to optimize in the process in order to gradually improve the production rate and production economy, but this is a major milestone that has now been achieved”, Nanologica’s CEO Andreas Bhagwani comments.